| Baer AN, Freer JP, Milling DA, Potter WR, Ruchlin H, Zinnerstrom KH; Breaking bad news: use of cancer survivors in role-playing exercises.; J Palliat Med; 2008 Jul; 11(6); 885-892 |
| Freer JP, Eubanks M, Parker B, Hershey CO; Advance directives: ambulatory patients‘ knowledge and perspectives.; Am J Med; 2006 Dec; 119(12); 1088-1088 |
| Freer JP; Physician Service to the Underserved; AMA Virtual Mentor; 2004 Apr; 6(4); |
| Freer JP; CPR for patients labeled DNR.; Ann Intern Med; 2003 Oct; 139(8); 704-704 |
| Jack Freer, Stephen Wear; Culture Wars In New York State: Ongoing Political Resistance by Religious Groups to The Family Care Health Decisions Act; Christian Bioethics; 2002 Apr; 8(1); 9-24 |
| Freer JP, Zinnerstrom KL; The palliative medicine extended standardized patient scenario: a preliminary report.; J Palliat Med; 2001 Jan; 4(1); 49-56 |
| Freer JP; Congress and the pain relief promotion act.; West J Med; 2000 Jan; 172(1); 5-6 |
| Wear SE, Freer JP, Koczwara B; The Commercialization of Human Body Parts: Public Policy Considerations; Persons and Their Bodies: Rights, Responsibilities and Relationships; 1999; |
| Freer JP, Bentley DW; The Role of Antibiotics in Comfort Care; Controversies in Ethics and Long-Term Care; 1995; |
| Freer J; Incapacitated patients can still have a voice; Wall Street Journal; 1994 Jun; |
| Freer JP; Providing CPR survival data to patients.; J Gen Intern Med; 1994 Jan; 9(1); 57-58 |
| Freer JP; Decision making in an incapacitated patient.; J Clin Ethics; 1993 Apr; 4(1); 55-58 |
| Freer JP; Depression and decision making.; J Am Geriatr Soc; 1993 Mar; 41(3); 345-346 |
| Freer JP; ‘Futility‘ as a criterion in limiting treatment.; N Engl J Med; 1992 Oct; 327(17); 1240-1240 |
| Freer JP, Truog RD, Fackler JC, Bartholme WG, Morgan H; Brain death and the termination of life support: case and analysis.; J Clin Ethics; 1992; 3(1); 78-82 |
| Freer JP, Scharf LM; The right to leave a hospital against medical advice.; N Y State J Med; 1991 Dec; 91(12); 554-554 |
| Morris ME, Freer JP, Watson WA; Sulfate homeostasis. III. Effect of chronic naproxen or sulindac treatment
on inorganic sulfate disposition in arthritic patients with renal impairment.; Pharm Res; 1991 Feb; 8(2); 242-246 |
| Morris ME, Freer JP, Watson WA; Sulfate homeostasis. III. Effect of chronic naproxen or sulindac treatment on inorganic sulfate disposition in arthritic patients with renal impairment.; Pharm Res; 1991 Feb; 8(2); 242-246 |
| Freer JP; Death and dignity: The case of Diane; N Engl J Med; 1991; 325(9); 658-658 |
| Freer,Jack; Clark, Elizabeth; The Living Will: A Guide to Health Care Decision Making; Patient Information Booklet; 1990 Jul; |
| Watson WA, Kalb RE, Siskin SB, Freer JP, Krochmal L; The Safety of Halobetasol 0.05% Ointment in the Treatment of Psoriasis.; Pharmacotherapy; 1990; 10(2); 107-111 |
| Freer JP; New York State‘s do-not-resuscitate law.; N Y State J Med; 1989 Jul; 89(7); 424-425 |
| Gregoire SL, Grasela TH, Freer JP, Tack KJ, Schentag JJ; Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.; Antimicrob Agents Chemother; 1987 Mar; 31(3); 375-378 |
| Watson WA, Freer JP, Katz RS, Basch C; Kidney function during naproxen therapy in patients at risk for renal insufficiency.; Semin Arthritis Rheum; 1987 Feb; 17(3 Sup); 12-16 |
| Freer JP; Chronic vegetative states: intrinsic value of biological process.; J Med Philos; 1984 Nov; 9(4); 395-407 |
View map